Updates

Cineworld

July 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

A strong update sent the shares flying to new highs of 745p. Cineworld noted group revenues rose 15.8% on a like-for-like basis (21.3% on an actual basis) in the 19 weeks to 12 May. It was a poorly kept secret in truth with UK cinema data previously disclosing an 11% spike in admissions in Q1 but nevertheless very satisfactory.The UK (55% EBITDA) grew sales 17.3% (against strong comparatives: +5.3% a year ago) with box office revenues 15.9% higher and retail income up 19%. Rest of the World (45% EBITDA) increased revenues 13.3% with box office income up 13.6% and retail almost 21%.Looking forward, the film slate for the rest of H1 is strong with “Wonder Woman”, “Pirates of the Caribbean: Dead Men Tell no Tal ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Fevertree

SSP Group

Cineworld - Exciting film slate and pent up demand could drive re-rating (September 2021)

Cineworld (April 2020)

Cineworld (February 2020)

Cineworld (September 2019)

Cineworld - Sale and leaseback yields special dividend (July 2019)

Cineworld - Results trigger broker upgrades (May 2019)

Cineworld - Cinema chain transformed by US acquisition (April 2019)

Cineworld (July 2018)

Cineworld - Transformational US acquisition (March 2018)

Cineworld - Cinema operator boosted by Hollywood blockbuster (October 2017)

Cineworld - Acquires five cinemas for Â£94m (October 2016)

Cineworld (May 2016)

Cineworld (March 2016)

Cineworld (October 2015)

Cineworld - Cinema chain to benefit from strong film release schedule (September 2015)

Cineworld - Second largest cinema chain expanding rapidly (July 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X